CN Bio raised $21 million in a first close of its Series B fundraising round with Bayland Capital and founding shareholder, CN Innovations Holdings.
14 April 2024
14 April 2024
Total investments received (USD): 33M
Round value (USD): 21M
Round investors: Bayland Capital
Company: CN Bio
Related deals
Mimica raised a $26.2 million Series B round led by Paladin Capital Group, with Khosla Ventures, LGVP, and Entrepreneurs First
Investments
14 September 2025
Synthesized in a $20M Series A funding round led by redalpine, with participation from IQ Capital, Mercia Ventures, UBS, and Seedcamp.
Investments
14 September 2025
Fyxer raised a $30m Series B led by Madrona, with participation from Lakestar.
Investments
01 September 2025
Cyted Health raises €37.5 million in a Series B financing round led by EQT Life Sciences, Advent Life and British Business Bank, w/ Morningside and BGF.
Investments
01 August 2025
Monet to raise £17m in a seed round with Force Over Mass and British angel investors.
Investments
24 June 2025
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain